Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008771 |
---|---|
Receipt number | R000010308 |
Scientific Title | Phase II study of pemetrexed or pemetrexed plus bevacizumab for previously untreated elderly non-squamous non-small cell lung cancer |
Date of disclosure of the study information | 2012/08/27 |
Last modified on | 2021/02/15 10:55:11 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/08/26 12:07:22 | ||
2 | Update | 2012/08/27 17:28:52 | UMIN ID1 |
|
3 | Update | 2016/10/06 15:48:20 | Randomization unit Key inclusion criteria Key inclusion criteria Key exclusion criteria |
|
4 | Update | 2016/10/06 17:22:11 | Email Name of primary person or sponsor Organization |
|
5 | Update | 2016/10/06 17:22:35 | Recruitment status |
|
6 | Update | 2021/02/15 10:55:11 | Recruitment status Date of IRB Last follow-up date Date analysis concluded |